A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
New York City mayors past and present attended a celebration of the 10th anniversary of Cornell Tech, the technology and engineering-focused campus that Cornell launched in 2012 with its academic partner, the Technion-Israel Institute of Technology.
A class of proteins, known as TMEM16 scramblases, permit rearrangement of lipids in the cell membrane chiefly by thinning the membrane, according to a new model by Weill Cornell Medicine investigators.
Computing-related retraumatization can be lessened or avoided in a few low- or no-cost ways, according to research co-led by Nicola Dell and Tom Ristenpart of Cornell Tech and the Cornell Ann S. Bowers College of Computing and Information Science.
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia, according to a preclinical study by investigators at Weill Cornell Medicine.
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.
President Martha E. Pollack joined Deans Augustine M.K. Choi and Barbara Hempstead in conferring degrees on students graduating from Weill Cornell Medical College and Weill Cornell Graduate School of Medical Sciences, in the first in-person ceremony since the beginning of the COVID-19 pandemic.
A protein called CDC7, long thought to play an essential role early in the cell division process, is in fact replaceable by another protein called CDK1, according to a study by investigators at Weill Cornell Medicine and the Dana Farber Cancer Institute.
